Quick Answer
ENDONOVO THERAPEUTICS, INC. reported Shares Outstanding of 213.23 million shares for fiscal year 2022.
ENDONOVO THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2022 | 213.23M | +186.2% |
| 2021 | 74.50M | +203.6% |
| 2020 | 24.54M | +1963.3% |
| 2019 | 1.19M | +175.9% |
| 2018 | 431,063 | -99.9% |
| 2017 | 316.95M | +135.9% |
| 2016 | 134.34M | +24.4% |
| 2016 | 108.03M | +3.1% |
| 2015 | 104.80M | +1.5% |
| 2015 | 103.29M | +26.9% |
| 2014 | 81.43M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | 318.75M | +100.2% | +14.3% |
| June 30, 2023 | 278.80M | +85.3% | +3.2% |
| March 31, 2023 | 270.29M | +232.3% | +26.8% |
| December 31, 2022 | 213.23M | +186.2% | +33.9% |
| September 30, 2022 | 159.23M | +130.1% | +5.8% |
| June 30, 2022 | 150.43M | +148.0% | +85.0% |
| March 31, 2022 | 81.33M | +57.8% | +9.2% |
| December 31, 2021 | 74.50M | +203.6% | +7.7% |
- ENDONOVO THERAPEUTICS, INC. showed an increase of +186.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2022 period, ENDONOVO THERAPEUTICS, INC.’s shares outstanding has grown by 161.9% (from 81.43 million shares to 213.23 million shares).
- The most recent figure is from ENDONOVO THERAPEUTICS, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: